Co-Diagnostics, Inc. 8-K Filing
Ticker: CODX · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1692415
| Field | Detail |
|---|---|
| Company | Co-Diagnostics, Inc. (CODX) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Co-Diagnostics, Inc. (ticker: CODX) to the SEC on Dec 30, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ch registered Common Stock, par value $0.001 per share CODX The NASDAQ Capital M).
How long is this filing?
Co-Diagnostics, Inc.'s 8-K filing is 3 pages with approximately 868 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 868 words · 3 min read · ~3 pages · Grade level 10.9 · Accepted 2025-12-30 09:15:26
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share CODX The NASDAQ Capital M
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex3-1.htm (EX-3.1) — 15KB
- ex99-1.htm (EX-99.1) — 14KB
- 0001493152-25-029513.txt ( ) — 242KB
- codx-20251229.xsd (EX-101.SCH) — 3KB
- codx-20251229_lab.xml (EX-101.LAB) — 33KB
- codx-20251229_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CO-DIAGNOSTICS, INC. Date: December 30, 2025 By: /s/ Brian Brown Brian Brown Chief Financial Officer (Principal Financial and Accounting Officer)